FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B
The single-dose medicine "represents important progress" as the first-ever gene therapy for the rare disorder, the FDA said. ”The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men.”
Source: cbsnews.com
Press Announcements - FDA approves first leadless pacemaker to treat heart rhythm disorders: The U.S. Food and Drug Administration
Press Announcements - FDA approves first leadless pacemaker to treat heart rhythm disorders: The U.S. Food and Drug Administration today approved the first pacemaker that does not require the use of wired leads to provide an electrical connection between the pulse-generating device and the heart. While...
Source: fda.gov
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley Edited by André Sofair, MD, MPH, and William E. Chavey,
FDA Approves Less Expensive Insulin Glargine: By Kristin J. Kelley
Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS
The FDA has approved an insulin glargine injection (marketed as Basaglar) for treating type 1 (adult and pediatric patients) and … NEJM Journal Watch.
Source: jwatch.org
FDA Approves Two New Treatments for Diabetes NEJM Journal Watch.
FDA Approves Two New Treatments for Diabetes NEJM Journal Watch.
Source: jwatch.org
RSS feed